Naperville, IL -- (SBWIRE) -- 12/03/2013 -- Reportstack, provider of premium market research reports announces the addition of MediPoint: Peripheral Vascular Stents for the Lower Extremity - Global Analysis and Market Forecasts market report to its offering
Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone.
The global peripheral vascular stent (PVS) market is steadily growing in the 10 countries covered in the report, including the US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India.
Through The publisher’s analysis, it is evident that currently the peripheral vascular stent market for the lower extremity is saturated with bare metal stents, followed by covered stents. However, as clinical data and appropriate reimbursement and costs are established, adoption of innovative stent technologies such as drug-eluting stents and bioabsorbable stents will increase in the future.
By the end of the forecast period, the competitive landscape will experience significant change due to the launch of bioabsorbable stents in the market, the expansion of approved indications to include infrapopliteal artery lesions and the entry of new companies such as 480 Biomedical.
Questions Answered in this Report
What is the current perception and adoption of vascular stents for treating indications, including the iliac, femoropopliteal and infrapopliteal arteries in the lower extremity?
Bare metal and covered stents have been on the market for many years; however, unmet needs still exist with respect to patency and restenosis and treating challenging lesions in the femoropopliteal and infrapopliteal arteries. How will drug-eluting and bioabsorbable stents fulfil the unmet needs of the peripheral stent market for the lower extremity?
What is the current perception and adoption of innovative stent platforms such as drug-eluting and bioabsorbable stents in the major markets? How will adoption of these stent technologies affect adoption of bare metal and covered stents?
A majority of pipeline products are drug-eluting bioabsorbable stents. As more bioabsorbable stents receive approval, how will new entrants impact the peripheral vascular stent market for the lower extremity?
The global PVS market for the lower extremity is forecast to steadily increase in the future. What are the key factors and opportunities that will drive the market in terms of future adoption rates leading to a mature market?
Regions Covered: US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India.
Market Model Features
An interactive excel forecast model based on primary research interviews and surveys with KOLs, physicians, industry participants and distributors is included in this report*. The forecast model is robust, fully transparent, and easy to navigate. Moreover, our models support data presented in the reports and the complete methodology is outlined in the report and the model.
*Interactive excel forecast model only available to clients purchasing a site license or higher.
What Physicians Think
“What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
To view the table of contents for this market research report please visit
http://www.reportstack.com/product/146864/medipoint-peripheral-vascular-stents-for-the-lower-extremity-global-analysis-and-market-forecasts.html
Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
###